VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PEN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PENPenumbra, Inc.
$316.63$12.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPENBalance Sheet

Penumbra, Inc. (PEN) Balance Sheet

13Y historyFree accessUpdated daily

The company maintains a conservative financial profile with a debt-to-equity ratio of 0.15 as of 2026Q1, supported by a robust $241.3M cash position.

PEN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets1.28B1.22B951.13M915.4M755.7M681.47M617.7M463.13M410.73M382.23M263.83M244.36M115.3M62.24M
Cash & Short-Term Investments241.29M186.9M340.13M289.19M188.03M254.88M264.83M189.39M200.89M214.59M128.75M148.8M51.54M13.68M
Cash Only241.29M186.9M324.4M167.49M69.86M59.38M69.67M72.78M67.85M50.64M13.24M19.55M3.29M4.13M
Short-Term Investments0015.73M121.7M118.17M195.5M195.16M116.61M133.04M163.95M115.52M129.26M48.25M9.54M
Accounts Receivable183.29M190.02M167.67M201.77M203.38M133.94M114.61M105.9M81.9M58.01M43.34M29.44M20.57M13.15M
Days Sales Outstanding45.9549.4151.2369.5787.6365.3974.6470.6167.1863.4460.0757.7559.8154.03
Inventory438.54M431.55M406.74M388.02M334.01M263.5M219.53M152.99M115.74M94.9M73.01M56.76M33.45M27.07M
Days Inventory Outstanding332.84341.51337.7376.79390.84353.33360.55318.3277.19297.02288.14333.96286.15318.98
Other Current Assets412.28M408.22M36.59M36.42M30.28M000009.5M1.3M6.61M5.18M
Total Non-Current Assets623.03M609.84M582.06M640.9M615.19M562.78M205.28M202.77M104.28M94.43M44.43M19.49M6.08M8.91M
Property, Plant & Equipment329.54M317M268.45M280.5M280.41M227.09M127.43M135.45M35.41M30.9M21.46M8.95M5.18M2.03M
Fixed Asset Turnover4.74x4.43x4.45x3.77x3.02x3.29x4.40x4.04x12.57x10.80x12.27x20.79x24.23x43.75x
Goodwill166.59M166.75M165.83M166.27M166.05M166.39M8.37M7.66M7.81M8.18M0000
Intangible Assets5.95M6.19M6.51M83.09M91.72M90.62M10.64M25.41M27.25M23.78M0000
Long-Term Investments0000000003.87M05K06M
Other Non-Current Assets120.96M119.9M141.27M25.88M12.79M12.98M8.71M2.95M875K1.02M487K393K328K454K
Total Assets1.9B1.83B1.53B1.56B1.37B1.24B822.98M665.9M515.01M476.67M308.25M263.85M121.38M71.15M
Asset Turnover0.81x0.77x0.78x0.68x0.62x0.60x0.68x0.82x0.86x0.70x0.85x0.71x1.03x1.25x
Asset Growth %65.36%19.13%-1.49%13.53%10.18%51.19%23.59%29.3%8.04%54.63%16.83%117.37%70.61%-
Total Current Liabilities211.73M183.13M158.34M151.14M144.93M123.2M105.93M91.05M66.06M51.58M35.8M28.15M20.82M15.84M
Accounts Payable43.66M34.74M31.33M27.16M26.68M13.42M14.11M15.11M8.18M6.76M4.11M2.57M2.35M1.31M
Days Payables Outstanding26.2327.4926.0126.3731.221823.1731.4419.5821.1516.2215.120.0915.46
Short-Term Debt16.53M16.23M000000000000
Deferred Revenue (Current)0006.99M9.16M00000344K526K1.59M1.09M
Other Current Liabilities151.54M132.16M112.43M0009.81M1.82M9.3M8.88M14.39M10.56M8.03M7.95M
Current Ratio6.02x6.64x6.01x6.06x5.21x5.53x5.83x5.09x6.22x7.41x7.37x8.68x5.54x3.93x
Quick Ratio3.95x4.29x3.44x3.49x2.91x3.39x3.76x3.41x4.47x5.57x5.33x6.66x3.93x2.22x
Cash Conversion Cycle352.55363.44362.92420447.25400.73412.02357.47324.79339.31331.99376.61325.88357.55
Total Non-Current Liabilities212.9M215.78M223.91M226.22M227.1M167.13M79.26M89.24M26.53M24.68M5.91M3.18M112.93M63.37M
Long-Term Debt199.65M203.47M000000000006M
Capital Lease Obligations406.81M0208.8M220.91M223.82M163.57M71.25M73.99M000000
Deferred Tax Liabilities0000004.78M4M4.17M3.3M0000
Other Non-Current Liabilities13.25M12.32M15.11M5.31M3.28M3.56M3.23M11.24M22.36M21.38M5.91M3.18M112.93M57.37M
Total Liabilities424.63M398.92M382.25M377.36M372.03M290.32M185.19M180.29M92.59M76.26M41.71M31.33M133.75M79.21M
Total Debt216.18M219.7M223.39M234.34M235.77M173.55M77.28M82.3M000006M
Net Debt-25.11M32.8M-101.02M66.86M165.91M114.17M7.61M9.52M-67.85M-50.64M-13.24M-19.55M-3.29M1.87M
Debt / Equity0.15x0.15x0.19x0.20x0.24x0.18x0.12x0.17x------
Debt / EBITDA1.08x1.06x6.77x2.32x7.75x19.48x-1.48x------
Net Debt / EBITDA-0.13x0.16x-3.06x0.66x5.46x12.82x-0.17x-12.76x-10.24x-13.98x-3.30x-0.88x-
Interest Coverage304.65x-15.72x46.80x3.23x-4.43x--------
Total Equity1.47B1.43B1.15B1.18B998.86M953.93M637.79M485.61M422.42M400.41M266.55M232.52M-12.37M-8.06M
Equity Growth %80.02%24.04%-2.38%18.03%4.71%49.57%31.34%14.96%5.5%50.22%14.63%1979.73%-53.44%-
Book Value per Share37.2736.3329.3130.0626.4025.1817.8313.3911.7111.347.9616.35-0.50-0.33
Total Shareholders' Equity1.47B1.43B1.15B1.18B998.86M953.93M641.5M485.89M422.24M400.41M266.55M232.52M-12.37M-8.06M
Common Stock39K39K38K39K38K37K36K35K34K33K31K30K5K4K
Retained Earnings270.27M237.69M60M134.86M43.9M45.91M40.62M57.52M9.06M2M-2.66M-17.48M-19.84M-14.99M
Treasury Stock00000000000000
Accumulated OCI2.08M4.35M-5.84M-3.15M-8.12M-2.63M2.54M-2.32M-1.94M1.57M-4.69M-2.12M-864K796K
Minority Interest000000-3.71M-279K175K00000

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetHealthy
Cash FlowImproving
Top Statement Risk

Competitive VTE market saturation

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Expansion Supports Growth

According to recent balance sheet data, Penumbra has grown its total assets from $1.5B in 2024Q3 to $1.9B in 2026Q1, reflecting a consistent expansion strategy that appears to be successfully funding the company's ongoing penetration into the peripheral vascular and neurovascular procedural markets.

The steady increase in total assets suggests that the company is effectively deploying capital to scale its manufacturing and distribution infrastructure. This trajectory indicates a business model that is prioritizing market share capture over immediate balance sheet contraction, which appears sustainable given the current asset-to-liability profile.

Minimal Leverage Enhances Financial Flexibility

As reported in financial statements, Penumbra maintains a conservative debt-to-equity ratio of 0.15 as of 2026Q1, signaling that the company relies minimally on external financing to fund its operations and remains well-insulated from the volatility of rising interest rates in the current macroeconomic environment.

The low leverage profile suggests that management is prioritizing financial independence, which provides a significant buffer against potential cyclical downturns in hospital capital expenditure. Investors should monitor whether this debt-averse strategy persists as the company continues to invest in higher-cost, computer-assisted aspiration systems.

Robust Liquidity Buffers Operational Needs

Based on the provided quarterly figures, Penumbra’s current ratio of 6.02 in 2026Q1 demonstrates a substantial liquidity cushion, ensuring the company can comfortably meet its short-term obligations while maintaining the flexibility to navigate the inventory-heavy consignment model inherent in the medical device industry.

This high current ratio suggests that the company is holding significant working capital, likely in the form of inventory and accounts receivable, which is typical for a business reliant on hospital-level consignment. The liquidity position appears more than adequate to support ongoing R&D and sales force expansion without requiring additional liquidity events.

Retained Earnings Drive Equity Growth

Analysis of the company's equity structure reveals that retained earnings have climbed to $270.3M in 2026Q1 from $26.0M in 2024Q3, indicating that internal profit generation is becoming a primary driver of shareholder value rather than reliance on external capital raises or dilutive equity issuance.

The consistent growth in retained earnings suggests that the company's core procedural business is generating meaningful surplus capital. This trend warrants further investigation into whether this capital will be reinvested into the 'Real System' platform or returned to shareholders, given the current lack of significant debt obligations.

Consignment Inventory Risks Warrant Monitoring

Data from recent filings indicates that Penumbra's asset base includes significant investments in PPE and inventory, which, when combined with the company's consignment-heavy sales model, creates a potential risk of obsolescence as product iterations like the Thunderbolt system accelerate the lifecycle of older catheter generations.

While the balance sheet appears healthy, the reliance on consignment inventory means that a portion of reported assets may be subject to rapid devaluation if clinical preferences shift away from older product lines. Investors should monitor inventory turnover ratios to ensure that the 'shadow inventory' held at hospitals remains productive and does not lead to future write-downs.

PEN — Frequently Asked Questions

Quick answers to the most common questions about buying PEN stock.

What are the total assets of Penumbra, Inc. (PEN)?

As of 2025, Penumbra, Inc. (PEN) had total assets of $1.83B including $1.22B in current assets.

How much debt does Penumbra, Inc. (PEN) have?

Penumbra, Inc. (PEN) carries total debt of $219.7M, offset by $186.9M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Penumbra, Inc.?

Penumbra, Inc. (PEN) has total shareholders' equity (book value) of $1.43B ($36.33 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Penumbra, Inc.'s current ratio and liquidity?

Penumbra, Inc. (PEN) reported a current ratio of 6.64x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.